2. Academic Validation
  3. Identification of prostaglandin D2 receptor antagonists based on a tetrahydropyridoindole scaffold

Identification of prostaglandin D2 receptor antagonists based on a tetrahydropyridoindole scaffold

  • Bioorg Med Chem Lett. 2008 Apr 15;18(8):2696-700. doi: 10.1016/j.bmcl.2008.03.015.
Christian Beaulieu 1,  Daniel Guay,  Zhaoyin Wang,  Yves Leblanc,  Patrick Roy,  Claude Dufresne,  Robert Zamboni,  Carl Berthelette,  Stephen Day,  Nancy Tsou,  Danielle Denis,  Gillian Greig,  Marie-Claude Mathieu,  Gary O'Neill
Affiliations

Affiliation

  • 1 Department of Medicinal Chemistry, Merck Frosst Canada & Co., 16711 Trans Canada Hwy, Kirkland, Que., Canada. [email protected]
PMID: 18359630 DOI: 10.1016/j.bmcl.2008.03.015
Abstract

A new series of indole-based antagonists of the PGD(2) receptor subtype 1 (DP1 receptor) was identified and the progress of the structure-activity relationship study to the identification of potent and selective antagonists is presented. Selective DP1 antagonists with high potency and selectivity were prepared. Of particular interest is the DP1 antagonist 26 with a K(i) value of 1 nM for the DP1 receptor and an IC(50) value of 4.6 nM in a DP1 functional assay for the inhibition of the PGD(2) induced cAMP production in platelet rich plasma (PRP).

Figures
Products